Your browser doesn't support javascript.
loading
Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy.
Perera, Jonathan R; AlFaraidy, Meshal; Ibe, Izuchukwu; Aoude, Ahmed; Acem, Ibtissam; van de Sande, Michiel A J; Dessureault, Mireille; Turcotte, Robert E; Mottard, Sophie; Basile, Georges; Isler, Marc; Saint-Yves, Hugo; Eastley, Nicholas; Stevenson, Jonathan; Houdek, Matthew T; Chung, Peter W M; Griffin, Anthony M; Ferguson, Peter; Wunder, Jay S; Tsoi, Kim M.
Afiliação
  • Perera JR; Orthopaedic Oncology, Royal National Orthopaedic Hospital, London, United Kingdom. Electronic address: Jonathan.Perera@nhs.net.
  • AlFaraidy M; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Ibe I; Orthopaedic Oncology, University of Mississippi Medical Center, USA.
  • Aoude A; Orthopaedic Oncology, McGill University, Montreal, QC, Canada.
  • Acem I; Surgical Oncology and Gastrointestinal Surgery Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Orthopaedic Oncology Leiden University Medical Centre, Leiden, the Netherlands.
  • van de Sande MAJ; Orthopaedic Oncology Leiden University Medical Centre, Leiden, the Netherlands.
  • Dessureault M; Orthopaedic Oncology, McGill University, Montreal, QC, Canada.
  • Turcotte RE; Orthopaedic Oncology, McGill University, Montreal, QC, Canada.
  • Mottard S; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada.
  • Basile G; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada.
  • Isler M; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada.
  • Saint-Yves H; Orthopaedic Oncology Université de Montreal, Montreal, QC, Canada.
  • Eastley N; Orthopaedic Oncology, Royal Orthopaedic Hospital, Birmingham, United Kingdom.
  • Stevenson J; Orthopaedic Oncology, Royal Orthopaedic Hospital, Birmingham, United Kingdom.
  • Houdek MT; Orthopaedic Oncology, Mayo Clinic, Rochester, MN, USA.
  • Chung PWM; Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
  • Griffin AM; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Ferguson P; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Wunder JS; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
  • Tsoi KM; University Musculoskeletal Oncology Unit, Sinai Health System, Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Eur J Surg Oncol ; 49(2): 362-367, 2023 02.
Article em En | MEDLINE | ID: mdl-36243649
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Lipossarcoma Mixoide / Lipossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Lipossarcoma Mixoide / Lipossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article